Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.172 EUR | -1.01% | -15.68% | -9.01% |
14/06 | Abionyx: positive response from FDA, share price rises | CF |
13/06 | ABIONYX Pharma Completes Pre-IND Meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis | CI |
- Stock Market
- Equities
- ABNX Stock
- News ABIONYX Pharma
- Trading Ideas